Congenital adrenal hyperplasia: clinical symptoms and diagnostic methods

• Authors: Rafał Podgórski , David Aebisher , Monika Stompor , Dominika Podgórska , Artur Mazur
• Languages of publication: EN

Abstracts

EN

The aim of this paper is a straightforward presentation of the steroidogenesis process and the most common type of congenital adrenal hyperplasia (CAH) - 21-hydroxylase deficiency - as well as the analytical diagnostic methods that are used to recognize this disease. CAH is a family of common autosomal recessive disorders characterized by impaired adrenal cortisol biosynthesis with associated androgen excess due to a deficiency of one or more enzymes in the steroidogenesis process within the adrenal cortex. The most common and prototypical example of the CAH disorders group (90-95%) is caused by 21-hydroxylase deficiency. Less frequent types of CAH are 11β-hydroxylase deficiency (up to 8% of cases), 17α-hydroxylase deficiency, 3β-hydroxysteroid dehydrogenase deficiency, P450 oxidoreductase deficiency and StAR deficiencies. In the 21-hydroxylase and 11β-hydroxylase deficiency, only adrenal steroidogenesis is affected, whereas a defect in 3β-hydroxysteroid dehydrogenase or 17α-hydroxylase also involves gonadal steroid biosynthesis. Many countries have introduced newborn screening programs based on immunoassays measuring 17-hydroxyprogesterone from blood spots used for other neonatal screening tests which enable faster diagnosis and treatment of CAH. Currently, chromatographic techniques coupled with mass spectrometry are gaining popularity due to an increase in the reliability of the test results.

Keywords

EN

Congenital Adrenal Hyperplasia; CAH; steroidogenesis; 21-hydroxylase deficiency

• Publisher: Polish Biochemical Society
• Journal: Acta Biochimica Polonica
• Year: 2018
• Volume: 65
• Issue: 1
• Pages: 25-33

Dates

published

2018

received

2017-10-20

revised

2017-12-29

accepted

2018-02-02

(unknown)

2018-03-15

Contributors

author

Rafał Podgórski

• Centre for Innovative Research in Medical and Natural Sciences, University of Rzeszów, Rzeszów, Poland
• Department of Biochemistry, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland

author

David Aebisher

• Department of Human Immunology, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland

author

Monika Stompor

• Centre for Innovative Research in Medical and Natural Sciences, University of Rzeszów, Rzeszów, Poland;
• Department of Biochemistry, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland

author

Dominika Podgórska

• Department of Rheumatology, Clinical Provincial Hospital No. II in Rzeszów, Rzeszów, Poland

author

Artur Mazur

• Department of Pediatrics, Pediatric Endocrinology and Diabetes, Medical Faculty, University of Rzeszów, Rzeszów, Poland

References

• Agarwal AK, Auchus RJ (2005) Minireview: cellular redox state regulates hydroxysteroid dehydrogenase activity and intracellular hormone potency. Endocrinology 146: 2531-2538. doi: 10.1210/en.2005-0061.
• Akolekar R, Beta J, Picciarelli G, Ogilvie C, D'Antonio F (2015) Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 45: 16-26. doi: 10.1002/uog.14636.
• American College of Obstetricians and Gynecologists Committee on Genetics (2012) Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 120: 1532-1534. doi: 10.1097/01.AOG.0000423819.85283.f4.
• Arakane F, King SR, Du Y, Kallen CB, Walsh LP, Watari H, Stocco DM, Strauss JF (1997) Phosphorylation of steroidogenic acute regulatory protein (StAR) modulates its steroidogenic activity. J Biol Chem 272: 32656-32662.
• Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, Chalder SM, Borucka-Mankiewicz M, Hauffa BP, Malunowicz EM, Stewart PM, Shackleton CH (2004) Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 363: 2128-2135. doi: 10.1016/S0140-6736(04)16503-3.
• Azziz R, Hincapie LA, Knochenhauer ES, Dewailly D, Fox L, Boots LR (1999) Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 72: 915-925.
• Balducci R, Boscherini B, Mangiantini A, Morellini M, Toscano V (1994) Isolated precocious pubarche: an approach. J Clin Endocrinol Metab 79: 582-589. doi: 10.1210/jcem.79.2.8045980.
• Barnes ND, Atherden SM (1972) Diagnosis of congenital adrenal hyperplasia by measurement of plasma 17-hydroxyprogesterone. Arch Dis Child 47: 62-65. doi: 10.1136/adc.47.251.62.
• Bauland CG, Smit JM, Scheffers SM, Bartels RH, van den Berg P, Zeebregts CJ, Spauwen PH (2012) Similar risk for hemangiomas after amniocentesis and transabdominal chorionic villus sampling. J Obstet Gynaecol Res 38: 371-375. doi: 10.1111/j.1447-0756.2011.01717.x.
• Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA (2015) Severe salt-losing 3β-hydroxysteroid dehydrogenase deficiency: treatment and outcomes of HSD3B2 c.35G>A Homozygotes. J Clin Endocrinol Metab 100: E1105-E1115. doi: 10.1210/jc.2015-2098.
• Benn P, Borell A, Chiu R, Cuckle H, Dugoff L, Faas B, Gross S, Johnson J, Maymon R, Norton M, Odibo A, Schielen P, Spencer K, Huang T, Wright D, Yaron Y (2013) Position statement from the aneuploidy screening committee on behalf of the board of the international society for prenatal diagnosis. Prenat Diagn 33: 622-629. doi: 10.1002/pd.4139.
• Bronstad I, Breivik L, Methlie P, Wolff AS, Bratland E, Nermoen I, Lovas K, Husebye ES (2014) Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia. Endocr Connect 3: 67-74. doi: 10.1530/EC-14-0032.
• Bulsari K, Falhammar H (2017) Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Endocrine 55: 19-36. doi: 10.1007/s12020-016-1189-x.
• Carlson AD, Obeid JS, Kanellopoulou N, Wilson RC, New MI (1999) Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment. J Steroid Biochem Mol Biol 69: 19-29.
• Chan CL, McFann K, Taylor L, Wright D, Zeitler PS, Barker JM (2013) Congenital adrenal hyperplasia and the second newborn screen. J Pediatr 163: 109-113. e1. doi: 10.1016/j.jpeds.2013.01.002.
• Choi JH, Kim GH, Yoo HW (2016) Recent advances in biochemical and molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Pediatr Endocrinol Metab 21: 1. doi: 10.6065/apem.2016.21.1.1.
• Clayton PE, Miller WL, Oberfield SE, Ritzén EM, Sippell WG, Speiser PW, ESPE/ LWPES CAH Working Group (2002) Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res 58: 188-195. doi: 10.1159/000065490.
• Dacou-Voutetakis C, Dracopoulou M (1999) High incidence of molecular defects of the CYP21 gene in patients with premature adrenarche. J Clin Endocrinol Metab 84: 1570-1574. doi: 10.1210/jcem.84.5.5683.
• Decourt J, Jayle MF, Baulieu E (1957) Clinically late virilism with excretion of pregnanetriol and insufficiency of cortisol production]. Ann Endocrinol 18: 416-422.
• Delle Piane L, Rinaudo PF, Miller WL (2015) 150 Years of congenital adrenal hyperplasia: translation and commentary of De Crecchio's Classic Paper from 1865. Endocrinology 156: 1210-1217. doi: 10.1210/en.2014-1879.
• Demirci C, Witchel SF (2008) Congenital adrenal hyperplasia. Dermatol Ther 21: 340-353. doi: 10.1111/j.1529-8019.2008.00216.x.
• Devers PL, Cronister A, Ormond KE, Facio F, Brasington CK, Flodman P (2013) Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. J Genet Couns 22: 291-295. doi: 10.1007/s10897-012-9564-0.
• Eugster EA, Dimeglio LA, Wright JC, Freidenberg GR, Seshadri R, Pescovitz OH (2001) Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis. J Pediatr 138: 26-32. doi: 10.1067/mpd.2001.110527.
• Evans MI, Wapner RJ (2005) Invasive prenatal diagnostic procedures 2005. Semin Perinatol 29: 215-218. doi: 10.1053/j.semperi.2005.06.004.
• Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjöld A, Hagenfeldt K, Thorén M (2007) Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 92: 110-116. doi: 10.1210/jc.2006-1350.
• Falhammar H, Filipsson Nyström H, Wedell A, Brismar K, Thorén M (2013) Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia. Eur J Endocrinol 168: 331-341. doi: 10.1530/EJE-12-0865.
• Falhammar H, Nordenström A (2015) Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Endocrine 50: 32-50. doi: 10.1007/s12020-015-0656-0.
• Falhammar H, Wedell A, Nordenström A (2015) Biochemical and genetic diagnosis of 21-hydroxylase deficiency. Endocrine 50: 306-314. doi: 10.1007/s12020-015-0731-6.
• Ferguson JJ (1963) Protein synthesis and adrenocorticotropin responsiveness. J Biol Chem 238: 2754-2759.
• Gatelais F, Berthelot J, Beringue F, Descamps P, Bonneau D, Limal JM, Coutant R (2004) Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia. Pediatr Res 56: 701-705. doi: 10.1203/01.PDR.0000142733.50918.6E.
• Ghayee HK, Auchus RJ (2007) Basic concepts and recent developments in human steroid hormone biosynthesis. Rev Endocr Metab Disord 8: 289-300. doi: 10.1007/s11154-007-9052-2.
• Gonzalez FJ (1988) The molecular biology of cytochrome P450s. Pharmacol Rev 40: 243-288.
• Gurian EA, Kinnamon DD, Henry JJ, Waisbren SE (2006) Expanded newborn screening for biochemical disorders: the effect of a false-positive result. Pediatrics 117: 1915-1921. doi: 10.1542/peds.2005-2294.
• Kao PC, Machacek DA, Magera MJ, Lacey JM, Rinaldo P (2001) Diagnosis of adrenal cortical dysfunction by liquid chromatography-tandem mass spectrometry. Ann Clin Lab Sci 31: 199-204.
• Kashimada K, Ono M, Onishi T, Koyama S, Toyoura T, Imai K, Saisho S, Mizutani S (2008) Clinical course of patients with nonclassical 21-hydroxylase deficiency (21-OHD) diagnosed in infancy and childhood. Endocr J 55: 397-404.
• Kaur J, Casas L, Bose HS (2016) Lipoid congenital adrenal hyperplasia due to STAR mutations in a Caucasian patient. Endocrinol Diabetes Metab Case Rep 2016: 150119. doi: 10.1530/EDM-15-0119.
• King JL, Naber JM, Hopkin RJ, Repaske DR, Bailey L, Leslie ND (2001) Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia. Arch Pediatr Adolesc Med 155: 1038-1042.
• Knowles RL, Khalid JM, Oerton JM, Hindmarsh PC, Kelnar CJ, Dezateux C (2014) Late clinical presentation of congenital adrenal hyperplasia in older children: findings from national paediatric surveillance. Arch Dis Child 99: 30-34. doi: 10.1136/archdischild-2012-303070.
• Kohn B, Levine LS, Pollack MS, Pang S, Lorenzen F, Levy D, Lerner AJ, Rondanini GF, Dupont B, New MI (1982) Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 55: 817-827. doi: 10.1210/jcem-55-5-817.
• Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP (2000) Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 85: 1059-1065. doi: 10.1210/jcem.85.3.6441.
• Krone N, Dhir V, Ivison HE, Arlt W (2007) Congenital adrenal hyperplasia and P450 oxidoreductase deficiency. Clin Endocrinol (Oxf) 66: 162-172. doi: 10.1111/j.1365-2265.2006.02740.x.
• Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W, Shackleton CH (2010) Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J Steroid Biochem Mol Biol 121: 496-504. doi: 10.1016/j.jsbmb.2010.04.010.
• Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann Y, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Raymond C, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blöcker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowki J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S, Chen YJ, Szustakowki J; International Human Genome Sequencing Consortium (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921. doi: 10.1038/35057062.
• Lee MM, Rajagopalan L, Berg GJ, Moshang T (1989) Serum adrenal steroid concentrations in premature infants. J Clin Endocrinol Metab 69: 1133-1136. doi: 10.1210/jcem-69-6-1133.
• Lin-Su K, Harbison MD, Lekarev O, Vogiatzi MG, New MI (2011) Final adult height in children with congenital adrenal hyperplasia treated with growth hormone. J Clin Endocrinol Metab 96: 1710-1717. doi: 10.1210/jc.2010-2699.
• Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62: 768-775. doi: 10.1086/301800.
• Ma D, Ge H, Li X, Jiang T, Chen F, Zhang Y, Hu P, Chen S, Zhang J, Ji X, Xu X, Jiang H, Chen M, Wang W, Xu Z (2014) Haplotype-based approach for noninvasive prenatal diagnosis of congenital adrenal hyperplasia by maternal plasma DNA sequencing. Gene 544: 252-258. doi: 10.1016/j.gene.2014.04.055.
• Ma D, Yuan Y, Luo C, Wang Y, Jiang T, Guo F, Zhang J, Chen C, Sun Y, Cheng J, Hu P, Wang J, Yang H, Yi X, Wang W, Asan Xu Z (2017) Noninvasive prenatal diagnosis of 21-Hydroxylase deficiency using target capture sequencing of maternal plasma DNA. Sci Rep 7: 7427. doi: 10.1038/s41598-017-06828-2.
• Marumudi E, Khadgawat R, Surana V, Shabir I, Joseph A, Ammini AC (2013) Diagnosis and management of classical congenital adrenal hyperplasia. Steroids 78: 741-746. doi: 10.1016/j.steroids.2013.04.007.
• Merke DP, Bornstein SR (2005) Congenital adrenal hyperplasia. Lancet 365: 2125-2136.
• Mesiano S, Mellon SH, Gospodarowicz D, Di Blasio AM, Jaffe RB (1991) Basic fibroblast growth factor expression is regulated by corticotropin in the human fetal adrenal: a model for adrenal growth regulation. Proc Natl Acad Sci U S A 88: 5428-5432.
• Miller WL (2005) Minireview: regulation of steroidogenesis by electron transfer. Endocrinology 146: 2544-2550. doi: 10.1210/en.2005-0096.
• Miller WL (2012) The syndrome of 17,20 lyase deficiency. J Clin Endocrinol Metab 97: 59-67. doi: 10.1210/jc.2011-2161.
• Miller WL, Auchus RJ (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 32: 81-151. doi: 10.1210/er.2010-0013.
• Monostori P, Szabó P, Marginean O, Bereczki C, Karg E (2015) Concurrent confirmation and differential diagnosis of congenital adrenal hyperplasia from dried blood spots: application of a second-tier LC-MS/MS assay in a cross-border cooperation for newborn screening. Horm Res Paediatr 84: 311-318. doi: 10.1159/000439380.
• Moran C, Azziz R, Carmina E, Dewailly D, Fruzzetti F, Ibañez L, Knochenhauer ES, Marcondes JA, Mendonca BB, Pignatelli D, Pugeat M, Rohmer V, Speiser PW, Witchel SF (2000) 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol 183: 1468-1474. doi: 10.1067/mob.[phone].
• Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O (1993) The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12: 1-51. doi: 10.1089/dna.1993.12.1.
• New MI (2011) Ancient history of congenital adrenal hyperplasia. Endocr Dev 20: 202-211. doi: 10.1159/000321248.
• New MI (2003) Inborn errors of adrenal steroidogenesis. Mol Cell Endocrinol 211: 75-84. doi: 10.1016/j.mce.2003.09.013.
• New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, Chitayat D, Sun L, Zaidi M, Wilson RC, Yuen T (2013) Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci 110: 2611-2616. doi: 10.1073/pnas.1300057110.
• New MI, Carlson A, Obeid J, Marshall I, Cabrera MS, Goseco A, Lin-Su K, Putnam AS, Wei JQ, Wilson RC (2001) Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 86: 5651-5657. doi: 10.1210/jcem.86.12.8072.
• New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S, Levine LS (1983) Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 57: 320-326. doi: 10.1210/jcem-57-2-320.
• New MI, Tong YK, Yuen T, Jiang P, Pina C, Chan KC, Khattab A, Liao GJ, Yau M, Kim SM, Chiu RW, Sun L, Zaidi M, Lo YM (2014) Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal dna in maternal plasma. J Clin Endocrinol Metab 99: E1022-E1030. doi: 10.1210/jc.2014-1118.
• Ney RL, Dexter RN, Davis WW, Garren LD (1967) A Study of Mechanisms by Which Adrenocorticotropic Hormone maintains adrenal steroidogenic responsiveness. J Clin Invest 46: 1916-1924.
• Nimkarn S, New MI (2009) Prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Mol Cell Endocrinol 300: 192-196. doi: 10.1016/j.mce.2008.11.027.
• Ostlere LS, Rumsby G, Holownia P, Jacobs HS, Rustin MH, Honour JW (1998) Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne. Clin Endocrinol (Oxf) 48: 209-215.
• Pang S, Clark A, Neto EC, Giugliani R, Dean H, Winter J, Dhondt J-L, Farriaux JP, Graters A, Cacciari E (1993) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: newborn screening and its relationship to the diagnosis and treatment of the disorder. Screening 2: 105-139
• Pang S, Hotchkiss J, Drash AL, Levine LS, New MI (1977) Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 45: 1003-1008. doi: 10.1210/jcem-45-5-1003.
• Pang S, Murphey W, Levine LS, Spence DA, Leon A, LaFranchi S, Surve AS, New MI (1982) A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab 55: 413-420. doi: 10.1210/jcem-55-3-413.
• Pang S, Wallace MA, Hofman L, Thuline HC, Dorche C, Lyon IC, Dobbins RH, Kling S, Fujieda K, Suwa S (1988) Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81: 866-874.
• Pang SY, Legido A, Levine LS, Temeck JW, New MI (1987) Adrenal androgen response to metyrapone, adrenocorticotropin, and corticotropin-releasing hormone stimulation in children with hypopituitarism. J Clin Endocrinol Metab 65: 282-289. doi: 10.1210/jcem-65-2-282.
• Parsa AA, New MI (2017) Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia. J Steroid Biochem Mol Biol 165: 2-11. doi: 10.1016/j.jsbmb.2016.06.015.
• Penning TM (1997) Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr Rev 18: 281-305. doi: 10.1210/edrv.18.3.0302.
• Pon LA, Hartigan JA, Orme-Johnson NR (1986) Acute ACTH regulation of adrenal corticosteroid biosynthesis. Rapid accumulation of a phosphoprotein. J Biol Chem 261: 13309-13316.
• Punthakee Z, Legault L, Polychronakos C (2003) Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency. J Pediatr 143: 402-405. doi: 10.1067/S0022-3476(03)00294-4.
• Quintos JB, Vogiatzi MG, Harbison MD, New MI (2001) Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 86: 1511-1517. doi: 10.1210/jcem.86.4.7412.
• Reisch N, Kuhnle U (2014) Geographical Endocrinology of Genetic Steroid Disorders. In Genetic Steroid Disorders. Elsevier, pp 351-356.
• Rivkees SA, Crawford JD (2000) Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics 106: 767-773.
• Shackleton CH (1986) Profiling steroid hormones and urinary steroids. J Chromatogr 379: 91-156.
• Speiser PW (2009) Nonclassic adrenal hyperplasia. Rev Endocr Metab Disord 10: 77-82. doi: 10.1007/s11154-008-9097-x.
• Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC, Endocrine Society (2010) Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95: 4133-4160. doi: 10.1210/jc.2009-2631.
• Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT, Lesser M, New MI, White PC (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90: 584-595. doi: 10.1172/JCI115897.
• Speiser PW, White PC (2003a) Congenital adrenal hyperplasia. N Engl J Med 349: 776-788. doi: 10.1056/NEJMra021561.
• Speiser PW, White PC (2003b) Congenital adrenal hyperplasia. N Engl J Med 349: 776-788.
• Stoner E, Dimartino-Nardi J, Kuhnle U, Levine LS, Oberfield SE, New MI (1986) Is salt-wasting in congenital adrenal hyperplasia due to the same gene as the fasciculata defect? Clin Endocrinol (Oxf) 24: 9-20.
• Temeck JW, Pang S, Nelson C, New MI (1987) Genetic defects of steroidogenesis in premature pubarche. J Clin Endocrinol Metab 64: 609-617. doi: 10.1210/jcem-64-3-609.
• Therrell BL, Adams J (2007) Newborn screening in North America. J Inherit Metab Dis 30: 447-465. doi: 10.1007/s10545-007-0690-z.
• Therrell BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S (1998) Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101: 583-590. doi: 10.1542/peds.101.4.583.
• Trapp CM, Speiser PW, Oberfield SE (2011) Congenital adrenal hyperplasia: an update in children. Curr Opin Endocrinol Diabetes Obes 18: 166-170. doi: 10.1097/MED.0b013e328346938c.
• Van der Kamp HJ, Noordam K, Elvers B, Van Baarle M, Otten BJ, Verkerk PH (2001) Newborn screening for congenital adrenal hyperplasia in the Netherlands. Pediatrics 108: 1320-1324.
• Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM, Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, Subramanian G, Thomas PD, Zhang J, Miklos GL, Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Francesco VD, Dunn P, Eilbeck K, Evangelista C, Gabrielian AE, Gan W, Ge W, Gong F, Gu Z, Guan P, Heiman TJ, Higgins ME, Ji RR, Ke Z, Ketchum KA, Lai Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov GV, Milshina N, Moore HM, Naik AK, Narayan VA, Neelam B, Nusskern D, Rusch DB, Salzberg S, Shao W, Shue B, Sun J, Wang ZY, Wang A, Wang X, Wang J, Wei MH, Wides R, Xiao C, Yan C, Yao A, Ye J, Zhan M, Zhang W, Zhang H, Zhao Q, Zheng L, Zhong F, Zhong W, Zhu SC, Zhao S, Gilbert D, Baumhueter S, Spier G, Carter C, Cravchik A, Woodage T, Ali F, An H, Awe A, Baldwin D, Baden H, Barnstead M, Barrow I, Beeson K, Busam D, Carver A, Center A, Cheng ML, Curry L, Danaher S, Davenport L, Desilets R, Dietz S, Dodson K, Doup L, Ferriera S, Garg N, Gluecksmann A, Hart B, Haynes J, Haynes C, Heiner C, Hladun S, Hostin D, Houck J, Howland T, Ibegwam C, Johnson J, Kalush F, Kline L, Koduru S, Love A, Mann F, May D, McCawley S, McIntosh T, McMullen I, Moy M, Moy L, Murphy B, Nelson K, Pfannkoch C, Pratts E, Puri V, Qureshi H, Reardon M, Rodriguez R, Rogers YH, Romblad D, Ruhfel B, Scott R, Sitter C, Smallwood M, Stewart E, Strong R, Suh E, Thomas R, Tint NN, Tse S, Vech C, Wang G, Wetter J, Williams S, Williams M, Windsor S, Winn-Deen E, Wolfe K, Zaveri J, Zaveri K, Abril JF, Guigó R, Campbell MJ, Sjolander KV, Karlak B, Kejariwal A, Mi H, Lazareva B, Hatton T, Narechania A, Diemer K, Muruganujan A, Guo N, Sato S, Bafna V, Istrail S, Lippert R, Schwartz R, Walenz B, Yooseph S, Allen D, Basu A, Baxendale J, Blick L, Caminha M, Carnes-Stine J, Caulk P, Chiang YH, Coyne M, Dahlke C, Mays AD, Dombroski M, Donnelly M, Ely D, Esparham S, Fosler C, Gire H, Glanowski S, Glasser K, Glodek A, Gorokhov M, Graham K, Gropman B, Harris M, Heil J, Henderson S, Hoover J, Jennings D, Jordan C, Jordan J, Kasha J, Kagan L, Kraft C, Levitsky A, Lewis M, Liu X, Lopez J, Ma D, Majoros W, McDaniel J, Murphy S, Newman M, Nguyen T, Nguyen N, Nodell M, Pan S, Peck J, Peterson M, Rowe W, Sanders R, Scott J, Simpson M, Smith T, Sprague A, Stockwell T, Turner R, Venter E, Wang M, Wen M, Wu D, Wu M, Xia A, Zandieh A, Zhu X (2001) The sequence of the human genome. Science 291: 1304-1351. doi: 10.1126/science.1058040.
• Verma S, Vanryzin C, Sinaii N, Kim MS, Nieman LK, Ravindran S, Calis KA, Arlt W, Ross RJ, Merke DP (2010) A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 72: 441-447. doi: 10.1111/j.1365-2265.2009.03636.x.
• Voutilainen R, Jääskeläinen J (2015) Premature adrenarche: etiology, clinical findings, and consequences. J Steroid Biochem Mol Biol 145: 226-236. doi: 10.1016/j.jsbmb.2014.06.004.
• Wedell A, Thilén A, Ritzén EM, Stengler B, Luthman H (1994) Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 78: 1145-1152. doi: 10.1210/jcem.78.5.8175971.
• White PC (2009) Neonatal screening for congenital adrenal hyperplasia. Nat Rev Endocrinol 5: 490-498. doi: 10.1038/nrendo.2009.148.
• Witchel SF (2017) Congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol 30: 520-534. doi: 10.1016/j.jpag.2017.04.001.
• Witchel SF (2010) The medical home concept and congenital adrenal hyperplasia: a comfortable habitat! Int J Pediatr Endocrinol 2010: 561526. doi: 10.1155/2010/561526.
• Wong T, Shackleton CH, Covey TR, Ellis G (1992) Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesteroneradioimmunoassays. Clin Chem 38: 1830-1837.
• Yau M, Khattab A, New MI (2016a) Prenatal diagnosis of congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 45: 267-281. doi: 10.1016/j.ecl.2016.01.001.
• Yau M, Nimkarn S, New MI (2016b) Congenital Adrenal Hyperplasia. In Genetic Diagnosis of Endocrine Disorders, pp 203-210. Elsevier.

Identifiers

DOI

10.18388/abp.2017_2343